Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 2NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Squamous Cell Carcinoma of Head and Neck 4Breast Neoplasms 4Sarcoma 2Ovarian Neoplasms 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Large B-Cell, Diffuse 2Lung Neoplasms 2Head and Neck Neoplasms 2Central Nervous System Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Burkitt Lymphoma 2Astrocytoma 2Spinal Cord Neoplasms 1Recurrence 1Radiation Injuries 1Radiation Fibrosis Syndrome 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Optic Nerve Glioma 1Medulloblastoma 1Lymphoma, T-Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Follicular 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, AIDS-Related 1Lymphoma 1Lymphedema 1Localized Advanced Rectal Adenocarcinoma 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myelomonocytic, Acute 1

Interventions

Cytarabine 2pegaspargase 1palbociclib 1carmustine, poliferprosan 20 drug combination 1Vincristine 1Stem Cell Transplantation 1Standard of Care 1Specimen Handling 1Prednisone 1Prednisolone 1Practice Guidelines as Topic 1Peripheral Blood Stem Cell Transplantation 1Methotrexate 1Melphalan 1Magnetic Resonance Spectroscopy 1Leukapheresis 1Hydrocortisone 1Hematopoietic Stem Cell Mobilization 1Etoposide 1Drug Therapy 1Doxorubicin 1Carmustine 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Lymphoma, T-Cell × Drug Therapy × Clear all
NCT06724237 2026-05-15

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

Eastern Cooperative Oncology Group

Phase 3 Recruiting
294 enrolled
Lymphoid

Lymphoma, T-Cell, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡